-
July 23, 2020 Lupin Receives Tentative Approval for Empagliflozin and Linagliptin Tablets
-
June 11, 2020 Lupin Receives Approval for Albendazole Tablets USP
-
June 8, 2020 U.S. FDA Grants Mexiletine Orphan Drug Designation
-
June 4, 2020 Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
-
June 3, 2020 Lupin Signs Distribution Agreement in Key EU Territories for Orphan Drug NaMuscla®
-
June 2, 2020 Lupin Receives Approval for Meloxicam Capsules
-
May 28, 2020 Lupin FY2020 Results
-
May 22, 2020 Lupin Receives Approval for Trientine Hydrochloride Capsules USP
-
May 19, 2020 Lupin Launches Authorized Generic Version of Apriso®
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications